MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-GJ-01-0007241
Naarini Molbio Pharma Private Limited - pharma in Ahmedabad, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹2.71 Cr
▲ 84% YoY
Net profit · FY 2024
₹9.84 Lakh
Net margin 3.6%
EBITDA · FY 2024
₹22.31 Lakh
EBITDA margin 8.2%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1.5 Lakh
Issued & subscribed
Open charges
₹20.27 Lakh
Secured borrowings
Company age
7 yrs
Est. 2019
Directors on board
3
As per MCA filings
About Naarini Molbio Pharma Private Limited
Data last updated:
Naarini Molbio Pharma Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 February 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24100GJ2019PTC106530. Its GSTIN is 24AAGCN4042G1ZR (Gujarat). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1.5 Lakh. It is led by directors including Tushar Rajendra Patil and Narendrakumar Surendrakumar Bobby.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A1 – 61 Sun View Tower Bhuyangdev Road Ghatlodiya, Ahmedabad, Gujarat, India – 380061.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.71 Cr, a growth of 84% compared to the previous year. For the same year it recorded a net profit of ₹9.84 Lakh (net margin 3.6%) and EBITDA of ₹22.31 Lakh (EBITDA margin 8.2%). Revenue has grown at a compounded annual rate (CAGR) of 53% over three years.
The company is associated with 1 brand: Naarini Molbio Pharma. As per MCA filings, the company has open charges of ₹20.27 Lakh on record.
Naarini Molbio Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0007241). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website naarini.com.
Company details
CIN U24100GJ2019PTC106530
Registration Number 106530
Incorporation Date 11 February 2019
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-GJ-01-0007241
Key People
Tushar Rajendra Patil Director Narendrakumar Surendrakumar Bobby Director Ritesh Kumar Mishra Director Recognitions & Rankings of Naarini Molbio Pharma
Contact details
Naarini Molbio Pharma Private Limited's registered office is in Ahmedabad, Gujarat. Its website is naarini.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressA1 – 61 Sun View Tower Bhuyangdev Road Ghatlodiya, Ahmedabad, Gujarat, India – 380061
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Naarini Molbio Pharma Private Limited, buy the company report.
Comprehensive company report
Naarini Molbio Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Naarini Molbio Pharma operates one associated brand: Naarini Molbio Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers chemical standards, solvents, and testing services for industries worldwide. | naarini.com |
Business activity
The main business activity of Naarini Molbio Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Naarini Molbio Pharma Private Limited, buy the company report.
Financials of Naarini Molbio Pharma Private Limited
FY 2025 filings availableNaarini Molbio Pharma Private Limited reported revenue of ₹2.71 Cr (up 84% YoY) for FY 2024.
Revenue · FY 2024
₹2.71 Cr ▲ 84%
Net profit · FY 2024
₹9.84 Lakh margin 3.6%
EBITDA · FY 2024
₹22.31 Lakh margin 8.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 84%
3 years · compounded
▲ 53%
EBITDA CAGR growth
1 year
▲ 95%
3 years · compounded
▲ 58%
Revenue has grown at a compounded annual rate (CAGR) of 53% over three years, including 84% growth in the latest year. EBITDA rose 95% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹22.31 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹9.84 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.2% | ||||
| Net Profit Margin | 3.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Naarini Molbio Pharma Private Limited, buy the company report.
Board of directors of Naarini Molbio Pharma Private Limited
Naarini Molbio Pharma has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Tushar Rajendra Patil | Director | 29 Jul 2021 | 5 Years 3 Months | Current |
| Narendrakumar Surendrakumar Bobby Also directs: Chemical Shoppe Private Limited | Director | 11 Feb 2019 | 7 Years 8 Months | Current |
| Ritesh Kumar Mishra | Director | 11 Feb 2019 | 7 Years 8 Months | Current |
Peer comparison
Naarini Molbio Pharma Private Limited is compared with the 9 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nexgenmed Pharmacy Private Limited | ₹2.71 Cr (FY 2025) | -14.0% | Chennai, Tamil Nadu, India | |||
| Pleasure Pharmaceauticals Private Limited | ₹2.71 Cr (FY 2025) | 3.0% | Delhi, India | |||
| Steadfast Office Automation Private Limited | ₹2.71 Cr (FY 2019) | 13.0% | Delhi, India | |||
| Evermark Polymers Private Limited | ₹2.71 Cr (FY 2025) | 5.0% | Vaishali Nagar, Rajasthan, India | |||
| Loomex Sports Private Limited | ₹2.71 Cr (FY 2025) | -17.0% | Meerut, Uttar Pradesh, India | |||
| Naarini Molbio Pharma Private Limitedthis company | ₹2.71 Cr (FY 2024) | ₹9.84 Lakh | 3.6% | 84.0% | Ahmedabad, Gujarat, India | |
| Maha Mrityunjai International Private Limited | ₹2.71 Cr (FY 2024) | 8.0% | Lucknow, Uttar Pradesh, India | |||
| Umar Medicare Private Limited | ₹2.71 Cr (FY 2022) | 269.0% | Delhi, India | |||
| Shenbaga Vinayagar Salterns Limited | ₹2.71 Cr (FY 2025) | 84.0% | Tuticorin, Tamil Nadu, India | |||
| Isolate Commercial Private Limited | ₹2.71 Cr (FY 2016) | 205.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Naarini Molbio Pharma Private Limited, buy the company report.
Auditor
Naarini Molbio Pharma Private Limited is audited by Rachit S Gohil & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Rachit S Gohil & Associates | FY 2023 | 172624 |
Shareholding
The shareholding of Naarini Molbio Pharma Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Naarini Molbio Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹20.27 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 11 Jul 2023 | 100758973 | Hdfc Bank Limited | ₹20.27 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Naarini Molbio Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Naarini Molbio Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Naarini Molbio Pharma has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAGCN4042G1ZR | Gujarat | Active | 03 Apr 2019 |
| 27AAGCN4042G1ZL | Maharashtra | Active | 21 Aug 2021 |
To see the full GST registrations and return filing status of Naarini Molbio Pharma Private Limited, buy the company report.
Recent activity
Naarini Molbio Pharma Private Limited has 4 board changes on record since 2019: 3 appointments and 1 cessation. The latest: Tushar Rajendra Patil ceased to be Additional Director on 30 Nov 2021.
AGM
Naarini Molbio Pharma Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Filing
Naarini Molbio Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 20.27 Lakh with Charge ID 100758973 was registered on 11 Jul 2023.
Ceased
Tushar Rajendra Patil ceased to be Additional Director.
Appointed
Tushar Rajendra Patil was appointed as Director.
Appointed
Narendrakumar Surendrakumar Bobby was appointed as Director.
Appointed
Ritesh Kumar Mishra was appointed as Director.
Incorporation
11 Feb 2019
Naarini Molbio Pharma Private Limited was registered on 11 Feb 2019 with Roc Ahmedabad & aged 7 years 8 months as per MCA records.
Frequently asked questions
Naarini Molbio Pharma is an active private limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 11 February 2019 (7+ years old) and is registered under CIN U24100GJ2019PTC106530.
Naarini Molbio Pharma has 3 current directors:
- Tushar Rajendra Patil - Director
- Narendrakumar Surendrakumar Bobby - Director
- Ritesh Kumar Mishra - Director
The latest financial statements of Naarini Molbio Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Naarini Molbio Pharma is 24AAGCN4042G1ZR, registered in Gujarat. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 27AAGCN4042G1ZL (Maharashtra).
The CIN (Corporate Identification Number) of Naarini Molbio Pharma is U24100GJ2019PTC106530. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Naarini Molbio Pharma was incorporated on 11 February 2019, making it 7+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Naarini Molbio Pharma by revenue are Nexgenmed Pharmacy Private Limited, Pleasure Pharmaceauticals Private Limited, Steadfast Office Automation Private Limited, Evermark Polymers Private Limited, Loomex Sports Private Limited and 4 more, all in the same principal business activity (wholesale trading).
Tushar Rajendra Patil ceased to be Additional Director on 30 Nov 2021. Tushar Rajendra Patil was appointed as Director on 29 Jul 2021. Narendrakumar Surendrakumar Bobby was appointed as Director on 11 Feb 2019. Naarini Molbio Pharma has 4 board changes on record in total.
Yes, Naarini Molbio Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-GJ-01-0007241).
Naarini Molbio Pharma can be reached through the website naarini.com. Its registered office is in Ahmedabad, Gujarat, India.
The registered office of Naarini Molbio Pharma is at A1 – 61 Sun View Tower Bhuyangdev Road Ghatlodiya, Ahmedabad, Gujarat, India – 380061.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages